82 results match your criteria: "Toulouse 3 university[Affiliation]"
Lancet Haematol
November 2024
Internal Medicine and Clinical Immunology Department, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.
Aliment Pharmacol Ther
January 2025
French Faecal Transplant Group (GFTF), France.
Gut
January 2025
Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain
Background: The microbiota is emerging as a key factor in the predisposition to insulin resistance and obesity.
Objective: To understand the interplay among gut microbiota and insulin sensitivity in multiple tissues.
Design: Integrative multiomics and multitissue approach across six studies, combining euglycaemic clamp measurements (used in four of the six studies) with other measurements of glucose metabolism and insulin resistance (glycated haemoglobin (HbA1c) and fasting glucose).
Gastroenterology
August 2024
Assistance Publique-Hopitaux de Paris FMT Center, Paris, France; Paris Center for Microbiome Medicine FHU, Paris, France; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Assistance Publique-Hopitaux, Gastroenterology Department, Saint-Antoine Hospital, Paris, France; Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
J Hepatol
July 2024
Internal Medicine- Department of Gastroenterology and Hepatology, Rangueil Hospital, Toulouse 3 University, Toulouse, France. Electronic address:
Lancet Infect Dis
February 2024
Department of Anesthesia and Critical Care, Toulouse University Hospital and Toulouse 3 University, Toulouse, France; INSERM UMR 1214, Toulouse NeuroImaging Center (ToNIC), Toulouse, France.
Thromb Res
September 2023
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de référence de la maladie de Rendu-Osler, 69677 Bron, France.
Background: It is unclear whether hereditary hemorrhagic telangiectasia (HHT) patients can tolerate antithrombotic therapies (AT) including antiplatelet (AP) and/or anticoagulant (AC) agents.
Objectives: Primary endpoint was tolerance to AT in HHT. Secondary endpoints were to identify factors associated with major bleeding events (MBE) and premature discontinuation of AT.
Viruses
December 2022
Paul-Brousse Hospital, Public Hospsitals of Paris, 12 Avenue Paul Vaillant Couturier, FHU Hépatinov, 94800 Villejuif, France.
Background: Direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection have been proven safe and effective in cirrhotic patients awaiting liver transplantation (LT). However, in the long term, data remain minimal regarding the clinical impact of viral eradication on patients listed for decompensated cirrhosis or hepatocellular carcinoma (HCC). We aimed to elucidate the clinical outcomes of patients regarding delisting and the evolution of HCC during the long-term follow-up.
View Article and Find Full Text PDFFront Allergy
September 2022
"Allergy / Environment" Research Team, Armand Trousseau Children Hospital, APHP, Paris, France.
About 10 years ago, a protein family was shown for the first time to contain allergenic members, gibberellin-regulated protein (GRP). The first reported member was from peach, Pru p 7. One can hypothesize that it was not detected before because its physicochemical characteristics overlap with those of lipid transfer protein (LTP), a well-known allergen, or because the exposure to GRP increased due to an increase in the gibberellin phythormone level in plant food, either exogenous or endogenous.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
November 2022
Sorbonne Université, APHP, Hôpital La Pitié-Salpêtrière, Institut E3M, Service de Médecine Interne 2; Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-Immunes Systémiques Rares, Paris, France.
Background: The systemic capillary leak syndrome (SCLS), also known as Clarkson disease, is a very rare condition characterized by recurrent life-threatening episodes of vascular hyperpermeability in the presence of a monoclonal gammopathy. Extended intravenous immunoglobulin (IVIG) treatment is associated with fewer recurrences and improved survival, but the optimal treatment dosage and duration remain unknown.
Objective: We aim to evaluate the safety of IVIG tapering and withdrawal in patients with SCLS.
Gastroenterology
September 2022
Department of Gastroenterology and Pancreatology, Toulouse Rangueil University Hospital, Toulouse 3 University, Toulouse, France.
Clin Res Hepatol Gastroenterol
July 2022
AP-HP, Hôpitaux Universitaires Paris Seine Saint-Denis, APHP, Liver Unit, Bobigny, France; Université Sorbonne Paris Nord, Bobigny, France; Inserm, UMR-1138 « Functional Genomics of solid tumors », Centre de Recherche des Cordeliers, Université de Paris, France. Electronic address:
Background & Aims: Prediction of hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C (HCV) who achieved a sustained virological response (SVR) after direct acting antivirals (DAAs) remains challenging.
Methods: Among HCC-free HCV patients with advanced fibrosis enrolled in the ANRS CO22 HEPATHER cohort who achieved SVR 12 weeks after treatment with DAAs, HCC predictive models were developed using Cox multivariable regression. The derived score was externally validated in a large Egyptian cohort.
J Nutr Health Aging
May 2022
Laurent Alric, Internal medicine department of digestive disease, Rangueil hospital, Toulouse 3 university, 1 avenue du professeur Jean-poulhès, TSA 50032, 31000 Toulouse, France,
Objectives: Fecal microbiota transplantation (FMT) is an innovative therapy indicated for the treatment of recurrent Clostridioides difficile infections. Although CDI and its complications are more common in very old patients (≥80 years) due to their comorbidities, frailty and senescence of the immune system, limited data are available for this older patient population.
Design: This was a single-center, real-life cohort study with retrospective outcome data registration, conducted at Toulouse, France.
Gastroenterology
August 2022
Department of Hepatology, Toulouse University Hospital, Toulouse 3 University, France.
BMC Infect Dis
January 2022
Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France.
Background: In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a previous history of decompensated cirrhosis following treatment or not with direct antiviral agents from the French ANRS CO22 HEPATHER cohort.
Methods: We identified HCV patients who had experienced an episode of decompensated cirrhosis.
J Neuroradiol
November 2022
Neuroradiology Department, Toulouse University Hospital, France. Electronic address:
Background: Head and neck paragangliomas are extradural masses rarely associated with subarachnoid haemorrhage.
Case: This case, for the first time, reports a fatal subarachnoid haemorrhage due to the rupture of a high-flow aneurysm located on an intradural artery feeding a jugulotympanic paraganglioma. Interestingly, this aneurysm was not present on an angiogram performed 7 years before, during the pre-surgical embolisation of the tumour.
Mov Disord
February 2022
Departments of Neurology and Clinical Pharmacology, Centre of Clinique Investigations, NS-Park/FCRIN Network, Centre of Excellence for Neurodegenerative Disorders (COEN) of Toulouse, CHU de Toulouse, Toulouse 3 University, NS-PARK/FCRIN Network, Toulouse, France.
Background: Excessive daytime sleepiness (EDS) is a frequent and disabling symptom of Parkinson's disease (PD) without approved treatment. THN102 is a novel combination drug of modafinil and low-dose flecainide.
Objective: The aim of this study is to evaluate the safety and efficacy of THN102 in PD patients with EDS.
Lancet Reg Health Eur
October 2021
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
Background: Faecal microbiota transplantation (FMT) is an emerging treatment modality, but its current clinical use and organisation are unknown. We aimed to describe the clinical use, conduct, and potential for FMT in Europe.
Methods: We invited all hospital-based FMT centres within the European Council member states to answer a web-based questionnaire covering their clinical activities, organisation, and regulation of FMT in 2019.
Clin Res Hepatol Gastroenterol
September 2021
Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Department of Public Health, Hôpital Saint-Antoine, Paris, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France. Electronic address:
Background & Aims: The factors predicting hepatocellular carcinoma (HCC) occurrence in chronic hepatitis B need to be precisely known to improve its detection. We identified pathways and individual predictive factors associated with HCC in the ANRS CO22 HEPATHER cohort.
Methods: The study analyzed HBV-infected patients recruited at 32 French expert hepatology centers from August 6, 2012, to December 31, 2015.
BMJ
April 2021
University of Paris, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, F-75004 Paris, France.
Objectives: To describe neurodevelopment at age 5 among children born preterm.
Design: Population based cohort study, EPIPAGE-2.
Setting: France, 2011.
Genes Immun
December 2020
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
United European Gastroenterol J
March 2021
Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany.
Background: Faecal microbiota transplantation is an emerging therapeutic option, particularly for the treatment of recurrent Clostridioides difficile infection. Stool banks that organise recruitment and screening of faeces donors are being embedded within the regulatory frameworks described in the European Union Tissue and Cells Directive and the technical guide to the quality and safety of tissue and cells for human application, published by the European Council.
Objective: Several European and international consensus statements concerning faecal microbiota transplantation have been issued.
J Infect Dis
June 2021
Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Background: Spontaneous clearance of acute hepatitis C virus (HCV) infection is more common in women than in men, independent of known risk factors.
Methods: To identify sex-specific genetic loci, we studied 4423 HCV-infected individuals (2903 male, 1520 female) of European, African, and Hispanic ancestry. We performed autosomal, and X chromosome sex-stratified and combined association analyses in each ancestry group.
Genes Immun
November 2020
Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.
Clearance of acute infection with hepatitis C virus (HCV) is associated with the chr19q13.13 region containing the rs368234815 (TT/ΔG) polymorphism. We fine-mapped this region to detect possible causal variants that may contribute to HCV clearance.
View Article and Find Full Text PDFParkinsonism Relat Disord
September 2020
Instituto de Medicina Molecular, Facultade de Medicina, University of Lisbon, Lisbon, Portugal; Laboratory of Clinical Pharmacology and Therapeutics, Facultade de Medicina, Universidade de Lisboa, Lisbon, Portugal; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. Electronic address:
People living with Parkinson's disease (PwP) experience a wide range of motor and non-motor symptoms associated with increasing complexity of care delivery. A multispecialty approach has been presented as an intuitive solution for tailored and comprehensive care delivery. Nevertheless, past trials of both multidisciplinary or interdisciplinary care models in PD suggested no measurable change to a small benefit in quality of life (QoL) and failed to show economic sustainability.
View Article and Find Full Text PDF